tetano
Editor, Senior Moderator
PLoS One
. 2024 Apr 3;19(4):e0297344.
doi: 10.1371/journal.pone.0297344. eCollection 2024. Clinical characteristics and prognosis of patients with COVID-19 on mechanical ventilation undergoing continuous renal replacement therapy
Dae-Eun Choi[SUP] 1 [/SUP], Duk Ki Kim[SUP] 2 [/SUP], Sunghoon Park[SUP] 3 [/SUP], Su Hwan Lee[SUP] 4 [/SUP], Onyu Park[SUP] 5 [/SUP], Taehwa Kim[SUP] 6 [/SUP], Hye Ju Yeo[SUP] 6 [/SUP], Jin Ho Jang[SUP] 6 [/SUP], Woo Hyun Cho[SUP] 6 [/SUP], Song I Lee[SUP] 2 [/SUP]; Korean Intensive Care Study Group
Affiliations
Background: The coronavirus disease (COVID-19) pandemic has significantly strained global healthcare, particularly in the management of patients requiring mechanical ventilation (MV) and continuous renal replacement therapy (CRRT). This study investigated the characteristics and prognoses of these patients.
Methods: This multicenter retrospective cohort study gathered data from patients with COVID-19 across 26 medical centers. Logistic analysis was used to identify the factors associated with CRRT implementation.
Results: Of the 640 patients with COVID-19 who required MV, 123 (19.2%) underwent CRRT. Compared to the non-CRRT group, the CRRT group was older and exhibited higher sequential organ failure assessment scores. The incidence of hypertension, diabetes, cardiovascular disease, chronic neurological disease, and chronic kidney disease was also higher in the CRRT group. Moreover, the CRRT group had higher intensive care unit (ICU) (75.6% vs. 26.9%, p < 0.001) and in-hospital (79.7% vs. 29.6%, p < 0.001) mortality rates. CRRT implementation was identified as an independent risk factor for both ICU mortality (hazard ratio
:1.833, 95% confidence interval [CI]:1.342-2.505, p < 0.001) and in-hospital mortality (HR: 2.228, 95% CI: 1.648-3.014, p < 0.001). Refractory respiratory failure (n = 99, 19.1%) was the most common cause of death in the non-CRRT death group, and shock with multi-organ failure (n = 50, 40.7%) was the most common cause of death in the CRRT death group. Shock with multi-organ failure and cardiac death were significantly more common in the CRRT death group, compared to non-CRRT death group.
Conclusion: This study indicates that CRRT is associated with higher ICU and in-hospital mortality rates in patients with COVID-19 who require MV. Notably, the primary cause of death in the CRRT group was shock with multi-organ failure, emphasizing the severe clinical course for these patients, while refractory respiratory failure was most common in non-CRRT patients.
. 2024 Apr 3;19(4):e0297344.
doi: 10.1371/journal.pone.0297344. eCollection 2024. Clinical characteristics and prognosis of patients with COVID-19 on mechanical ventilation undergoing continuous renal replacement therapy
Dae-Eun Choi[SUP] 1 [/SUP], Duk Ki Kim[SUP] 2 [/SUP], Sunghoon Park[SUP] 3 [/SUP], Su Hwan Lee[SUP] 4 [/SUP], Onyu Park[SUP] 5 [/SUP], Taehwa Kim[SUP] 6 [/SUP], Hye Ju Yeo[SUP] 6 [/SUP], Jin Ho Jang[SUP] 6 [/SUP], Woo Hyun Cho[SUP] 6 [/SUP], Song I Lee[SUP] 2 [/SUP]; Korean Intensive Care Study Group
Affiliations
- PMID: 38568934
- DOI: 10.1371/journal.pone.0297344
Background: The coronavirus disease (COVID-19) pandemic has significantly strained global healthcare, particularly in the management of patients requiring mechanical ventilation (MV) and continuous renal replacement therapy (CRRT). This study investigated the characteristics and prognoses of these patients.
Methods: This multicenter retrospective cohort study gathered data from patients with COVID-19 across 26 medical centers. Logistic analysis was used to identify the factors associated with CRRT implementation.
Results: Of the 640 patients with COVID-19 who required MV, 123 (19.2%) underwent CRRT. Compared to the non-CRRT group, the CRRT group was older and exhibited higher sequential organ failure assessment scores. The incidence of hypertension, diabetes, cardiovascular disease, chronic neurological disease, and chronic kidney disease was also higher in the CRRT group. Moreover, the CRRT group had higher intensive care unit (ICU) (75.6% vs. 26.9%, p < 0.001) and in-hospital (79.7% vs. 29.6%, p < 0.001) mortality rates. CRRT implementation was identified as an independent risk factor for both ICU mortality (hazard ratio
:1.833, 95% confidence interval [CI]:1.342-2.505, p < 0.001) and in-hospital mortality (HR: 2.228, 95% CI: 1.648-3.014, p < 0.001). Refractory respiratory failure (n = 99, 19.1%) was the most common cause of death in the non-CRRT death group, and shock with multi-organ failure (n = 50, 40.7%) was the most common cause of death in the CRRT death group. Shock with multi-organ failure and cardiac death were significantly more common in the CRRT death group, compared to non-CRRT death group.
Conclusion: This study indicates that CRRT is associated with higher ICU and in-hospital mortality rates in patients with COVID-19 who require MV. Notably, the primary cause of death in the CRRT group was shock with multi-organ failure, emphasizing the severe clinical course for these patients, while refractory respiratory failure was most common in non-CRRT patients.